Cyanosis laboratory findings: Difference between revisions
Jump to navigation
Jump to search
| Line 8: | Line 8: | ||
==Laboratory Findings== | ==Laboratory Findings== | ||
*Laboratory findings consistent with the diagnosis of | *Laboratory findings consistent with the diagnosis of [[cyanosis]] in older children include:<ref name="pmid28393783">{{cite journal |vauthors=Bhardwaj V, Malhotra P, Hasija S, Chowdury UK, Pangasa N |title=Coagulopathies in cyanotic cardiac patients: An analysis with three point - of - care testing devices (Thromboelastography, rotational thromboelastometry, and sonoclot analyzer) |journal=Ann Card Anaesth |volume=20 |issue=2 |pages=212–218 |date=2017 |pmid=28393783 |pmc=5408528 |doi=10.4103/aca.ACA_4_17 |url=}}</ref> | ||
* [[Polycythemia]] due to secondary [[erythrocytosis]] | |||
**[[ | * Elevated [[prothrombin time]] and [[partial thromboplastin time]] | ||
**[[ | * Decreased levels of factors 5,7,8,9: qualitative and quantitative | ||
**[[ | * [[Platelet disorder]] | ||
**[[ | * Increased [[fibrinolysis]] and paradoxical [[thrombotic]] tendency | ||
* [[Proteinuria]] | |||
* [[Hyperuricemia]] | |||
* [[Renal failure]] | |||
* [[Uric acid]] [[nephrolithiasis]] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 10:17, 21 October 2020
|
Cyanosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cyanosis laboratory findings On the Web |
|
American Roentgen Ray Society Images of Cyanosis laboratory findings |
|
Risk calculators and risk factors for Cyanosis laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Overview
Laboratory findings consistent with the diagnosis of cyanosis include measuring deoxygenated hemoglobin, oxygen saturation, arterial blood gas to check PaO2, hematocrit, electrolyte imbalance.
Laboratory Findings
- Polycythemia due to secondary erythrocytosis
- Elevated prothrombin time and partial thromboplastin time
- Decreased levels of factors 5,7,8,9: qualitative and quantitative
- Platelet disorder
- Increased fibrinolysis and paradoxical thrombotic tendency
- Proteinuria
- Hyperuricemia
- Renal failure
- Uric acid nephrolithiasis
References
- ↑ Bhardwaj V, Malhotra P, Hasija S, Chowdury UK, Pangasa N (2017). "Coagulopathies in cyanotic cardiac patients: An analysis with three point - of - care testing devices (Thromboelastography, rotational thromboelastometry, and sonoclot analyzer)". Ann Card Anaesth. 20 (2): 212–218. doi:10.4103/aca.ACA_4_17. PMC 5408528. PMID 28393783.